Compare TALO & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TALO | AMPH |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.3B |
| IPO Year | N/A | 2014 |
| Metric | TALO | AMPH |
|---|---|---|
| Price | $11.01 | $26.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $14.30 | ★ $31.00 |
| AVG Volume (30 Days) | ★ 2.1M | 383.1K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.27 |
| Revenue | ★ $1,872,554,000.00 | $723,305,000.00 |
| Revenue This Year | N/A | $1.35 |
| Revenue Next Year | N/A | $5.10 |
| P/E Ratio | ★ N/A | $11.49 |
| Revenue Growth | ★ 0.06 | N/A |
| 52 Week Low | $6.23 | $20.39 |
| 52 Week High | $12.20 | $41.84 |
| Indicator | TALO | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 49.17 | 49.96 |
| Support Level | $10.64 | $25.16 |
| Resistance Level | $11.23 | $26.52 |
| Average True Range (ATR) | 0.39 | 0.86 |
| MACD | -0.13 | -0.11 |
| Stochastic Oscillator | 24.44 | 36.02 |
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.